JMJD6 and neuroblastoma: Kaplan–Meier survival analysis showed that high levels of JMJD6 mRNA expression in human neuroblastoma tissues were associated with poor prognosis in the 88 and the 476 neuroblastoma patients of the Versteeg and the Oberthuer datasets, respectively (p < 0.0001) (Fig. 1e).